ASPEN AEROGELS INC (ASPN) Stock Fundamental Analysis
USA - NYSE:ASPN - US04523Y1055 - Common Stock
3.43 USD
-0.19 (-5.25%)
3.4 USD
-0.03 (-0.87%)
Taking everything into account, ASPN scores 3 out of 10 in our fundamental rating. ASPN was compared to 82 industry peers in the Chemicals industry. ASPN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ASPN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
ASPN had negative earnings in the past year.
ASPN had a positive operating cash flow in the past year.
ASPN had negative earnings in 4 of the past 5 years.
ASPN had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
ASPN's Return On Assets of -62.12% is on the low side compared to the rest of the industry. ASPN is outperformed by 93.90% of its industry peers.
Looking at the Return On Equity, with a value of -99.85%, ASPN is doing worse than 85.37% of the companies in the same industry.
The Return On Invested Capital of ASPN (2.43%) is worse than 62.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -62.12% | ||
| ROE | -99.85% | ||
| ROIC | 2.43% |
ROA(3y)-5.96%
ROA(5y)-12.11%
ROE(3y)-8.57%
ROE(5y)-17.34%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ASPN has a worse Operating Margin (3.27%) than 69.51% of its industry peers.
With a decent Gross Margin value of 32.89%, ASPN is doing good in the industry, outperforming 65.85% of the companies in the same industry.
In the last couple of years the Gross Margin of ASPN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.27% | ||
| PM (TTM) | N/A | ||
| GM | 32.89% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y70.57%
GM growth 5Y16.45%
2. Health
2.1 Basic Checks
ASPN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ASPN has more shares outstanding than it did 1 year ago.
ASPN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ASPN has a worse debt to assets ratio.
2.2 Solvency
ASPN has an Altman-Z score of -0.52. This is a bad value and indicates that ASPN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ASPN (-0.52) is worse than 82.93% of its industry peers.
ASPN has a debt to FCF ratio of 46.99. This is a negative value and a sign of low solvency as ASPN would need 46.99 years to pay back of all of its debts.
ASPN has a Debt to FCF ratio of 46.99. This is comparable to the rest of the industry: ASPN outperforms 43.90% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that ASPN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.31, ASPN is in the better half of the industry, outperforming 78.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 46.99 | ||
| Altman-Z | -0.52 |
ROIC/WACC0.29
WACC8.38%
2.3 Liquidity
A Current Ratio of 3.94 indicates that ASPN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.94, ASPN belongs to the top of the industry, outperforming 90.24% of the companies in the same industry.
ASPN has a Quick Ratio of 3.33. This indicates that ASPN is financially healthy and has no problem in meeting its short term obligations.
ASPN has a better Quick ratio (3.33) than 93.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.94 | ||
| Quick Ratio | 3.33 |
3. Growth
3.1 Past
The earnings per share for ASPN have decreased strongly by -129.73% in the last year.
The Revenue for ASPN has decreased by -14.74% in the past year. This is quite bad
ASPN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.56% yearly.
EPS 1Y (TTM)-129.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.11%
Revenue 1Y (TTM)-14.74%
Revenue growth 3Y54.99%
Revenue growth 5Y26.56%
Sales Q2Q%-37.77%
3.2 Future
ASPN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.38% yearly.
Based on estimates for the next years, ASPN will show a quite strong growth in Revenue. The Revenue will grow by 9.96% on average per year.
EPS Next Y-846.37%
EPS Next 2Y-72.49%
EPS Next 3Y3.33%
EPS Next 5Y41.38%
Revenue Next Year-32.59%
Revenue Next 2Y-14.45%
Revenue Next 3Y0.58%
Revenue Next 5Y9.96%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ASPN. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 87.19, ASPN can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ASPN indicates a slightly more expensive valuation: ASPN is more expensive than 67.07% of the companies listed in the same industry.
ASPN is valuated expensively when we compare the Price/Forward Earnings ratio to 34.43, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 87.19 |
4.2 Price Multiples
69.51% of the companies in the same industry are more expensive than ASPN, based on the Enterprise Value to EBITDA ratio.
ASPN's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 105.21 | ||
| EV/EBITDA | 8.06 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-72.49%
EPS Next 3Y3.33%
5. Dividend
5.1 Amount
ASPN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.43
-0.19 (-5.25%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners73.41%
Inst Owner Change-1.8%
Ins Owners1.14%
Ins Owner Change0.09%
Market Cap282.49M
Revenue(TTM)352.85M
Net Income(TTM)-305.28M
Analysts75.71
Price Target9.77 (184.84%)
Short Float %12.46%
Short Ratio5.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-101.12%
Min EPS beat(2)-176.85%
Max EPS beat(2)-25.4%
EPS beat(4)2
Avg EPS beat(4)-32.06%
Min EPS beat(4)-176.85%
Max EPS beat(4)57.28%
EPS beat(8)6
Avg EPS beat(8)89.76%
EPS beat(12)10
Avg EPS beat(12)72.04%
EPS beat(16)10
Avg EPS beat(16)45.6%
Revenue beat(2)1
Avg Revenue beat(2)2.56%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)5.47%
Revenue beat(4)1
Avg Revenue beat(4)-0.43%
Min Revenue beat(4)-6.73%
Max Revenue beat(4)5.47%
Revenue beat(8)5
Avg Revenue beat(8)5.37%
Revenue beat(12)7
Avg Revenue beat(12)4.61%
Revenue beat(16)9
Avg Revenue beat(16)3.03%
PT rev (1m)0%
PT rev (3m)4.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)60.52%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 87.19 | ||
| P/S | 0.8 | ||
| P/FCF | 105.21 | ||
| P/OCF | 5.39 | ||
| P/B | 0.92 | ||
| P/tB | 0.92 | ||
| EV/EBITDA | 8.06 |
EPS(TTM)-0.11
EYN/A
EPS(NY)0.04
Fwd EY1.15%
FCF(TTM)0.03
FCFY0.95%
OCF(TTM)0.64
OCFY18.56%
SpS4.28
BVpS3.71
TBVpS3.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -62.12% | ||
| ROE | -99.85% | ||
| ROCE | 2.74% | ||
| ROIC | 2.43% | ||
| ROICexc | 3.79% | ||
| ROICexgc | 3.79% | ||
| OM | 3.27% | ||
| PM (TTM) | N/A | ||
| GM | 32.89% | ||
| FCFM | 0.76% |
ROA(3y)-5.96%
ROA(5y)-12.11%
ROE(3y)-8.57%
ROE(5y)-17.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y70.57%
GM growth 5Y16.45%
F-Score4
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 46.99 | ||
| Debt/EBITDA | 2.77 | ||
| Cap/Depr | 221.9% | ||
| Cap/Sales | 14.1% | ||
| Interest Coverage | 0.81 | ||
| Cash Conversion | 154.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.94 | ||
| Quick Ratio | 3.33 | ||
| Altman-Z | -0.52 |
F-Score4
WACC8.38%
ROIC/WACC0.29
Cap/Depr(3y)1152.87%
Cap/Depr(5y)727.63%
Cap/Sales(3y)63.74%
Cap/Sales(5y)41.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-129.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.11%
EPS Next Y-846.37%
EPS Next 2Y-72.49%
EPS Next 3Y3.33%
EPS Next 5Y41.38%
Revenue 1Y (TTM)-14.74%
Revenue growth 3Y54.99%
Revenue growth 5Y26.56%
Sales Q2Q%-37.77%
Revenue Next Year-32.59%
Revenue Next 2Y-14.45%
Revenue Next 3Y0.58%
Revenue Next 5Y9.96%
EBIT growth 1Y-73.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-34.26%
EBIT Next 3Y26.7%
EBIT Next 5Y26.71%
FCF growth 1Y100.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y182.02%
OCF growth 3YN/A
OCF growth 5YN/A
ASPEN AEROGELS INC / ASPN FAQ
Can you provide the ChartMill fundamental rating for ASPEN AEROGELS INC?
ChartMill assigns a fundamental rating of 3 / 10 to ASPN.
What is the valuation status for ASPN stock?
ChartMill assigns a valuation rating of 1 / 10 to ASPEN AEROGELS INC (ASPN). This can be considered as Overvalued.
How profitable is ASPEN AEROGELS INC (ASPN) stock?
ASPEN AEROGELS INC (ASPN) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for ASPN stock?
The Earnings per Share (EPS) of ASPEN AEROGELS INC (ASPN) is expected to decline by -846.37% in the next year.